UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

One year later, the Autobots and Terrans race against the Decepticons to collect the shards of the Emberstone before the mysteries buried beneath their sleepy town re-emerge to cause chaos. ABC iview ...

The Kwara State Ministry of Energy has commenced the inspection of 34 transformers earlier procured and distributed across various communities in the state.